STAT+: Vinay Prasad returns to the FDA, weeks after his ouster
HFO HFO Vinay Prasad returns to a top FDA role just weeks after his abrupt dismissal.
Previous Post
Cervical medial branch blocks may offer therapeutic benefit for facet-mediated neck pain
Next Post
New Leadership Presents “Good Opportunity” to Expand Community-Based Trials
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago